Evidence map›Paper›PMID 31306293›Full record

ArticleRetinal cases & brief reports2021

ENHANCED S-CONE SYNDROME: VISUAL FUNCTION, CROSS-SECTIONAL IMAGING, AND CELLULAR STRUCTURE WITH ADAPTIVE OPTICS OPHTHALMOSCOPY.

Michael J Ammar, Kurt T Scavelli, Katherine E Uyhazi, Emma C Bedoukian, Leona W Serrano, Ilaina D Edelstein, Grace Vergilio, Robert F Cooper, Jessica I W Morgan, Priyanka Kumar and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Retinal cases & brief reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Enhanced S-cone Syndrome, a Mini-review.Advances in experimental medicine and biology · 2023
    Review
  7. Bardet-Biedl syndrome-7 (Ophthalmic genetics · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Michael J AmmarScheie Eye Institute.
Kurt T ScavelliScheie Eye Institute.
Katherine E UyhaziScheie Eye Institute.
Emma C BedoukianThe Children's Hospital of Philadelphia; and.
Leona W SerranoScheie Eye Institute.
Ilaina D EdelsteinScheie Eye Institute.
Grace VergilioScheie Eye Institute.
Robert F CooperScheie Eye Institute.
Jessica I W MorganScheie Eye Institute.
Priyanka KumarThe Children's Hospital of Philadelphia; and.
Tomas S AlemanScheie Eye Institute.
Penn Presbyterian Medical Center · USChildren's Hospital of Philadelphia · US

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CLAIRE H MITCHELL · 1985 to 2026
$19.5M
Platform Technologies for Microscopic Retinal Imaging: Development & TranslationU01EY025477 · NEI · STANFORD UNIVERSITY · PI DUBRA, ALFREDO · 2015 to 2019
$4.4M
Retinal structure, function and response to gene therapyR01EY028601 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Jessica I.W. Morgan · 2018 to 2026
$3.6M
NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY028601NEI NIH HHS U01 EY025477
6 · The paper itself

Abstract

purposeTo describe in detail the phenotype of a patient with enhanced S-cone syndrome.

methodsWe describe a 13-year-old boy who presented with blurred vision, vitreous cells, cystoid macular edema refractory to steroid treatment, and a negative uveitic workup. The patient underwent a complete ophthalmic examination, full-field electroretinograms (ffERG), automatic static perimetry and multimodal imaging with spectral domain optical coherence tomography, and adaptive optics scanning laser ophthalmoscopy (AOSLO).

resultsSpectral domain optical coherence tomography demonstrated cystoid macular edema and a hyperthick, delaminated midperipheral retina. Fluorescein angiography did not demonstrate macular leakage. Rod-mediated ffERGs were undetectable, and there was a supernormal response to short-wavelength stimuli compared with photopically matched longer wavelengths of light consistent with enhanced S-cone syndrome. Gene screening was positive for compound heterozygous mutations NR2E3: a known (c.119-2 A>C) and a novel (c.119-1G>A) mutation. By perimetry, sensitivities were normal or above normal for short-wavelength stimuli; there was no detectable rod-mediated vision. AOSLO demonstrated higher than normal cone densities in the perifoveal retina and evidence for smaller outer segment cone diameters.

conclusionEvidence for supernumerary cones (at least twice the normal complement) by AOSLO and spectral domain optical coherence tomography was associated with supernormal S-cone sensitivities and electroretinogram responses confirming previous in vivo findings in postmortem human specimens. Smaller than normal cones in enhanced S-cone syndrome may represent "hybrid" photoreceptors analogous to the rd7/rd7 murine model of the disease.

Indexed as

Eye Diseases, HereditaryRetinal DegenerationVision DisordersAdolescentHumansMaleTomography, Optical Coherence

Identifiers

PMID31306293
PMCPMC6980308
OpenAlexW2958921446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.